In autoimmune diseases responding to TNF neutralisation, sparing TNF/TNFR1 pathway onmyeloid cells, through anti TNF T-cell targeted bi-specific antibodies for instance,should help keeping protection against new exposure to primary, acute TB infection,in patients screened for absence of previous TB exposure. The gene discussed is TNF; the disease is autoimmune disease.